Applied Therapeutics, Inc. (APLT) Tops Q3 EPS by 1c

Applied Therapeutics, Inc. (NASDAQ: APLT) reported Q3 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Applied Therapeutics, Inc. (APLT) click here.

You May Also Be Interested In

• Cerebras Systems Inc. (CBRS) Misses Q2 EPS by $2.80, Misses on Revenue; Offers FY26 Revenue Guidance
• Data I/o Corp (DAIO) Misses Q3 EPS by 3c
• Red Robin Gourmet Burgers (RRGB) Tops Q2 EPS by 10c; offers outlook